Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells
S. Sahu, M. Castro, J. J. Muldoon, K. Asija, S. K. Wyman, N. Krishnappa, L. de Onate, J. Eyquem, D. N. Nguyen, R. C. Wilson
This paper introduces PERC, a method for efficient CRISPR editing in primary human immune cells and HSPCs using a peptide reagent, achieving over 90% editing efficiency without specialized equipment.
bioRxiv · Jul 14, 2024Bioengineering